Skip to main content
Log in

4D-CT is Superior to Ultrasound and Sestamibi for Localizing Recurrent Parathyroid Disease

  • Endocrine Tumors
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Recurrent primary hyperparathyroidism (PHPT) presents a diagnostic challenge in localizing a hyperfunctioning gland. Although several imaging modalities are available for preoperative localization, 4D-CT is increasingly utilized for its ability to locate both smaller and previously unlocalized lesions. Currently, there is a paucity of data evaluating the utility of 4D-CT in the reoperative setting compared with ultrasound (US) and sestamibi. We aimed to determine the sensitivity of 4D-CT in localizing parathyroid adenomas in recurrent or persistent PHPT.

Methods

We performed a retrospective review of prospectively collected data from a tertiary-care hospital, and identified 58 patients who received preoperative 4D-CT with US and/or sestamibi between May 2008 and March 2016. Data regarding the size, shape, and number of parathyroid lesions were collected for each patient.

Results

A total of 62 lesions were identified intraoperatively among the 58 patients (6 with multigland disease) included in this investigation. 4D-CT missed 13 lesions identified intraoperatively, compared with 32 and 22 lesions missed by US and sestamibi, respectively. Sensitivity for correct lateralization of culprit lesions was 77.4% for 4D-CT, 38.5% for US, and 46% for sestamibi. 4D-CT was superior in lateralizing adenomas (49/62) compared with US (20/52; p < 0.001) and sestamibi (18/47; p < 0.001). The overall cure rate (6-month postoperative calcium < 10.7 mg/dL) was 89.7%. All patients with lesions correctly lateralized by 4D-CT were cured at 6 months.

Conclusion

4D-CT localized parathyroid adenomas with higher sensitivity among patients with recurrent or persistent PHPT compared with sestamibi or US-based imaging.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Liddy S, Worsley D, Torreggiani W, Feeney J. Preoperative imaging in primary hyperparathyroidism: literature review and recommendations. Can Assoc Radiol J. 2017;68(1):47–55.

    Article  PubMed  Google Scholar 

  2. Griffith B, Chaudhary H, Mahmood G, Carlin AM, Peterson E, Singer M, Patel SC. Accuracy of 4-dimensional computed tomography in poorly localized patients with primary hyperparathyroidism. Am J Neuroradiol. 2015;36(12):2373–9.

    Article  CAS  PubMed  Google Scholar 

  3. Wilhelm SM, Wang TS, Ruan DT, Lee JA, Asa SL, Duh Q, et al. The American association of endocrine surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surg. 2016;151(10):959–68.

    Article  PubMed  Google Scholar 

  4. Lebastchi AH, Donovan PI, Udelsman R. Paradigm shift in the surgical management of multigland parathyroid hyperplasia an individualized approach. JAMA Surg. 2014;149(11):1133–137.

    Article  PubMed  Google Scholar 

  5. Udelsman R, Donovan P, Sokoll L. One hundred consecutive minimally invasive parathyroid explorations. Ann Surg. 2000; 232(3):331–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Udelsman R. Six hundred fifty-six consecutive explorations for primary hyperparathyroidism. Ann Surg. 2002;235(5):665–70; discussion 670–2.

    Article  Google Scholar 

  7. Beyer T, Solorzano C, Starr F, Nilubol N, Prinz R. Parathyroidectomy outcomes according to operative approach. Am J Surg. 2007;193(3):368–72; discussion 372–3.

    Article  PubMed  Google Scholar 

  8. Morris LF, Zanocco K, Ituarte PH, Ro K, Duh QY, Sturgeon C, et al. The value of intraoperative parathyroid hormone monitoring in localized primary hyperparathyroidism: a cost analysis. Ann Surg Oncol. 2010;17(3):679–85.

    Article  PubMed  Google Scholar 

  9. Lubitz C, Hunter G, Hamberg L, Parangi S, Ruan D, Gawande A, et al. Accuracy of 4-dimensional computed tomography in poorly localized patients with primary hyperparathyroidism. Surgery. 2010;148 (6):1129–37.

    Article  PubMed  Google Scholar 

  10. Mortenson MM, Evans DB, Lee JE, Hunter GJ, Shellingerhout D, Vu D, et al. Parathyroid exploration in the reoperative neck: improved preoperative localization with 4D-computed tomography. J Am Coll Surg. 2008;206(5):889–95; discussion 895–6.

    Article  Google Scholar 

  11. Karakas E, Müller HH, Schlosshauer T, et al. Reoperations for primary hyperparathyroidism: improvement of outcome over 2 decades. Langenbecks Arch Surg. 2013;398(1):99–106.

    Article  PubMed  Google Scholar 

  12. Thompson GB, Grant CS, Perrier ND, Harman R, Hodgson SF, Ilstrup D, et al. Reoperative parathyroid surgery in the era of sestamibi scanning and intraoperative parathyroid hormone monitoring. Arch Surg. 1999;134(7):699–05.

    Article  CAS  PubMed  Google Scholar 

  13. Beland MD, Mayo-Smith WW, Grand DJ, Machan JT, Monchik JM. Dynamic MDCT for localization of occult parathyroid adenomas in 26 patients with primary hyperparathyroidism. AJR Am J Roentgenol. 2011;196(1):61–5.

    Article  PubMed  Google Scholar 

  14. Kuo L, Wachtel H, Fraker D, Kelz R. Reoperative parathyroidectomy: who is at risk and what is the risk? J Surg Res. 2014;191(2):256–61.

    Article  PubMed  Google Scholar 

  15. Kuhel WI, Kutler DI, Cohen M, Heineman T. Response to “parathyroid surgery: getting it right the first time”: parathyroid surgery: primum non nocere. Otolaryngol Head Neck Surg. 2016;154(2):397.

    Article  PubMed  Google Scholar 

  16. Day KM, Elsayed M, Beland MD, Monchik JM. The utility of 4-dimensional computed tomography for preoperative localization of primary hyperparathyroidism in patients not localized by sestamibi or ultrasonography. Surgery. 2015;157(3):534–39.

    Article  PubMed  Google Scholar 

  17. Galvin L, Oldan J, Bahl M, Eastwood J, Sosa J, Hoang J. Parathyroid 4D CT and scintigraphy: what factors contribute to missed parathyroid lesions? Otolaryngol Head Neck Surg. 2016;154 (5):847–53.

    Article  PubMed  Google Scholar 

  18. Hinson AM, Lee DR, Hobbs BA, Fitzgerald RT, Bodenner DL, Stack BC Jr. Preoperative 4D CT localization of nonlocalizing parathyroid adenomas by US and SPECT-CT. Otolaryngol Head Neck Surg. 2015;153(5):775–78.

    Article  PubMed  Google Scholar 

  19. Wagh ST, Razvi NA. Marascuilo method of multiple comparisons (an analytical study of caesarean section delivery). Int J Contemp Med Res. 2016;3(4):1137–40.

    Google Scholar 

  20. Suh YJ, Choi JY, Kim SJ, Chun IK, Yun TJ, Lee KE, et al. Comparison of 4D CT, ultrasonography, and sestamibi SPECT/CT in localizing single-gland primary hyperparathyroidism. Otolaryngol Head Neck Surg. 2015;152(3):438–43.

    Article  PubMed  Google Scholar 

  21. Ginsburg M, Christoforidis GA, Zivin SP, Obara P, Wroblewski K, Angelos P, et al. Adenoma localization for recurrent or persistent primary hyperparathyroidism using dynamic four-dimensional CT and venous sampling. J Vasc Interv Radiol. 2015;26(1):79–86.

    Article  PubMed  Google Scholar 

  22. Starker LF, Mahajan A, Björklund P, et al. 4D parathyroid CT as the Initial localization study for patients with de novo primary hyperparathyroidism. Ann Surg Oncol. 2011;18(6):1723–8.

    Article  PubMed  Google Scholar 

  23. Rodgers SE, Hunter GJ, Hamberg LM, et al. Improved preoperative planning for directed parathyroidectomy with 4-dimensional computed tomography. Surgery. 2006;140:932–40.

    Article  PubMed  Google Scholar 

  24. Bahl M, Sepahdari A, Sosa J, Hoang J. Parathyroid adenomas and hyperplasia on four-dimensional CT scans: three patterns of enhancement relative to the thyroid gland justify a three-phase protocol. Radiology. 2015;277(2):454–62.

    Article  PubMed  Google Scholar 

  25. Wang T, Cheung K, Farrokhyar F, Roman S, Sosa J. Would scan, but which scan? A cost-utility analysis to optimize preoperative imaging for primary hyperparathyroidism. Surgery. 2011;150(6):1286–94.

    Article  PubMed  Google Scholar 

  26. Cham S, Sepahdari AR, Hall KE, Yeh MW, Harari A. Dynamic parathyroid computed tomography (4dct4d-ct) facilitates reoperative parathyroidectomy and enables cure of missed hyperplasia. Ann Surg Oncol. 2015;22(11):3537–42.

    Article  PubMed  Google Scholar 

  27. Morris L, Lee S, Warneke C, Abadin S, Suliburk J, Romero Arenas M, et al. Fewer adverse events after reoperative parathyroidectomy associated with initial minimally invasive parathyroidectomy. Am J Surg. 2014;208(5):850–5.

    Article  PubMed  Google Scholar 

  28. Duke W, Vernon H, Terris D. Reoperative parathyroidectomy: overly descended superior adenoma. Otolaryngol Head Neck Surg. 2016;154(2):268–71.

    Article  PubMed  Google Scholar 

  29. McIntyre CJ, Allen JLY, Constantinides VA, Jackson JE, Tolley NS, Palazzo FF. Patterns of disease in patients at a tertiary referral centre requiring reoperative parathyroidectomy. Ann R Coll Surg Engl. 2015;97(8):598–02.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Disclosure

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Matthew A. Nehs MD.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hamidi, M., Sullivan, M., Hunter, G. et al. 4D-CT is Superior to Ultrasound and Sestamibi for Localizing Recurrent Parathyroid Disease. Ann Surg Oncol 25, 1403–1409 (2018). https://doi.org/10.1245/s10434-018-6367-z

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-018-6367-z

Keywords

Navigation